Siu Wing Fung Alfred 4

What Happened

• Siu Wing Fung Alfred, a director of NewGenIvf Group Ltd (NIVF), was granted 73,647 employee share options (derivative securities) on July 8, 2026. The Form 4 reports the options were acquired at an exercise price of $0.00 in the filing (the grant/award itself is reported as $0 in transaction value). This is an option award (grant), not an open-market purchase or sale of common shares.

Key Details

• Transaction date: 2026-07-08; Form 4 filed: 2026-07-09 (timely filing).
• Security: Employee share options (derivative); reported amount: 73,647 options; reported price: $0.00 (grant reported as $0).
• Vesting: Options granted under the Issuer’s 2024 Share Incentive Plan and an Option Agreement dated July 8, 2026. Vest monthly over 36 months; first tranche of 10% vests on August 8, 2026, then roughly 2.6% monthly thereafter (per filing footnotes).
• Shares/options owned after the transaction: not specified in the provided excerpt of the filing.
• Transaction code: A = Award/Grant. No exercise or sale reported in this filing.

Context

• These are option grants (a retention/incentive tool). They do not represent immediately tradable common shares until options are vested and exercised. The filing shows a standard multi-year vesting schedule; early vesting (10% after one month) begins Aug 8, 2026. Grants are common for directors/executives and are informational—by themselves they don’t indicate an immediate buy or sell of stock.